crystallize-portal-assets1000falseClinical Conversations Resources/2025-09-15T19:47:59.000Z"d41d8cd98f00b204e9800998ecf8427e"CRC64NVMEFULL_OBJECT0a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-biomarkers-treatment-par-ec-fr.pdf2025-10-09T18:14:31.000Z"d0d712be016941e518c0e2d7891ba95c"CRC64NVMEFULL_OBJECT4128672a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-biomarkers-treatment-par-ec-fr.pptx2025-10-08T15:05:52.000Z"4d694b032600554a91bdfc715657647b-14"CRC64NVMEFULL_OBJECT239675313a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-biomarkers-treatment-par-ec.pdf2025-10-09T18:13:43.000Z"5625ed827d68cab71b80f67a7de3ada3"CRC64NVMEFULL_OBJECT3891982a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-biomarkers-treatment-par-ec.pptx2025-10-08T15:11:25.000Z"bc9cc264911fcb42c28f54119d811670-14"CRC64NVMEFULL_OBJECT231111448a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-discussion-guide-en.pdf2025-09-23T18:51:11.000Z"a05101a37a780ad648a845dd41e9ba3e"CRC64NVMEFULL_OBJECT429610a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-discussion-guide-fr.pdf2025-09-23T18:51:16.000Z"febdf5ff69492fd69dbe2211b8390793"CRC64NVMEFULL_OBJECT438219a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-interpreting-clinical-data-par-ec-fr.pdf2025-10-09T18:14:34.000Z"613f526263051d5699a3259ce77463e8"CRC64NVMEFULL_OBJECT4222939a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-interpreting-clinical-data-par-ec-fr.pptx2025-10-08T15:05:52.000Z"e71732cc5fc42731be39811a8e857ffb-18"CRC64NVMEFULL_OBJECT305405219a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-interpreting-clinical-data-par-ec.pdf2025-10-09T18:13:45.000Z"1734651d3e15b98bd4600f2a7b01560e"CRC64NVMEFULL_OBJECT3982952a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-interpreting-clinical-data-par-ec.pptx2025-10-08T15:11:25.000Z"f0f67ca2ac51801f22b79f7bab413eac-18"CRC64NVMEFULL_OBJECT294114515a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-io-chemo-par-ec-trials-fr.pdf2025-10-09T18:14:35.000Z"c230dad47d8294c8c97b7d16e810a39a"CRC64NVMEFULL_OBJECT3929321a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-io-chemo-par-ec-trials-fr.pptx2025-10-08T15:05:52.000Z"8ba1aea89c1fda01b1c09220922a6c61-23"CRC64NVMEFULL_OBJECT389636363a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-io-chemo-par-ec-trials.pdf2025-10-09T18:13:46.000Z"060ddb3cbbd377d61313cb5a4bb6397e"CRC64NVMEFULL_OBJECT3709949a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-io-chemo-par-ec-trials.pptx2025-10-03T13:23:48.000Z"bee963aeac6e5f7f4f64e07026b0c574-22"CRC64NVMEFULL_OBJECT372186011a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-io-chemo-stage3-ec-fr.pdf2025-10-09T18:14:36.000Z"d0563c13e6e1222cd93bd0c4fc221dd3"CRC64NVMEFULL_OBJECT3496838a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-io-chemo-stage3-ec-fr.pptx2025-10-08T15:05:52.000Z"5282dbaec9afc68b040cde52d6087e98-15"CRC64NVMEFULL_OBJECT255002975a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-io-chemo-stage3-ec.pdf2025-10-09T18:13:47.000Z"1f18e406bfe73a99cc91b706702b674c"CRC64NVMEFULL_OBJECT3102573a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-io-chemo-stage3-ec.pptx2025-10-03T13:23:48.000Z"650c30beba809e13849025a4bf787d39-15"CRC64NVMEFULL_OBJECT242909112a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-treatment-stage3-dmmr-ec-case-fr.pdf2025-10-09T18:14:37.000Z"c536a324d2e5ae0a0ada3ce8a2e67efb"CRC64NVMEFULL_OBJECT4405313a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-treatment-stage3-dmmr-ec-case-fr.pptx2025-10-08T15:05:52.000Z"36b25e8f038f58125852061b77eb3df0-8"CRC64NVMEFULL_OBJECT131524429a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-treatment-stage3-dmmr-ec-case.pdf2025-10-09T18:13:48.000Z"de7c2e57e7598e03480dab8634109c3c"CRC64NVMEFULL_OBJECT4154805a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDClinical Conversations Resources/cc-treatment-stage3-dmmr-ec-case.pptx2025-10-08T15:11:25.000Z"3ba83bd4f096de9a64a8443c089dc57e-8"CRC64NVMEFULL_OBJECT122383855a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDCrystallize Broadcast Meeting Reel.pdf2025-05-02T16:53:53.000Z"764db79a76b66d4e8168be73a98fd470"CRC64NVMEFULL_OBJECT7061156a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDCrystallize Broadcast Meeting Reel.pptx2025-05-02T16:53:59.000Z"5f573720a073db21de1e46830ec22db2-2"CRC64NVMEFULL_OBJECT24297710a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDCrystallize National Broadcast full slide deck OLA EN.pdf2025-10-08T15:10:44.000Z"701701bf24fe1d5ea813fb38bcedf89b"CRC64NVMEFULL_OBJECT16260211a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDCrystallize National Broadcast full slide deck OLA EN.pptx2025-10-08T15:10:50.000Z"094fe2d5b461d95bed5f60500d3e5307"CRC64NVMEFULL_OBJECT14361407a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDCrystallize National Broadcast full slide deck OLA FR.pdf2025-10-08T15:10:46.000Z"1d54d56e163f2897e4d464a80b927bab"CRC64NVMEFULL_OBJECT7254385a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDCrystallize National Broadcast full slide deck OLA FR.pptx2025-10-08T15:10:48.000Z"f6abea8b7f4b1a671fcdcb3feae98bd1"CRC64NVMEFULL_OBJECT6598674a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDCrystallize National Broadcast_ Discussing Leading Therapies for Endometrial Cancer.mp42025-06-20T16:27:34.000Z"7854ee2e4689ecdbb6b3509db17fb2bb-85"CRC64NVMEFULL_OBJECT1456378024a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDCrystallize Satellite Patient Case.pdf2025-05-02T16:53:54.000Z"e9a971ef79ac5f4a7ee57bf1af93ac8d"CRC64NVMEFULL_OBJECT502080a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDCrystallize Satellite Patient Case.pptx2025-05-02T16:54:00.000Z"39d555f068196fd9d82cbc4009a442f4"CRC64NVMEFULL_OBJECT5010633a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDNational Broadcast Invite.pdf2025-04-15T18:19:48.000Z"b3d9fde30c7df2ab962d09e3814bf128"CRC64NVMEFULL_OBJECT198094a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDNational Broadcast Invite_FR.pdf2025-04-15T18:19:48.000Z"58fcf68f055031871a821abbaf8ba85c"CRC64NVMEFULL_OBJECT199621a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2501_Crystallize TTT_Data Slides.pdf2025-04-15T16:11:35.000Z"418d56781d7e25ff8587ed6238b1a843"CRC64NVMEFULL_OBJECT3552034a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2501_Crystallize TTT_Patient Profile 1.pdf2025-04-15T16:28:15.000Z"c902897e36e3d7e529d487d76cb150be"CRC64NVMEFULL_OBJECT226332a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2501_Crystallize TTT_Patient Profile 2.pdf2025-04-15T16:30:48.000Z"0e4af9c70092a159f19f2a63391feb1e"CRC64NVMEFULL_OBJECT227053a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2501_GSK Crystallize Moderator Guide_Final_06May2025-thumb.png2025-05-06T18:19:32.000Z"8fd4fb54aa759bfcbf8ce4ee106281be"CRC64NVMEFULL_OBJECT314076a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2501_GSK Crystallize Moderator Guide_Final_06May2025.docx2025-05-06T18:19:24.000Z"7aeb41be7b1e515b774c9c76d2b7bbf6"CRC64NVMEFULL_OBJECT6437272a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2501_GSK Crystallize Moderator Guide_Final_06May2025.pdf2025-05-06T18:19:54.000Z"9de9ba6ab52916515fafd0855a3a6bfb"CRC64NVMEFULL_OBJECT2207172a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2501_GSK+Crystallize+Moderator+Guide_Final_06May2025.pdf2025-05-06T18:32:05.000Z"9de9ba6ab52916515fafd0855a3a6bfb"CRC64NVMEFULL_OBJECT2207172a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2503_Crystallize Broadcast_Meeting Reel_Final_06May25_FRENCH.pdf2025-05-07T01:33:19.000Z"ab4388ea15ab9e20b932ba0bc5395265"CRC64NVMEFULL_OBJECT4730738a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2503_Crystallize Broadcast_Meeting Reel_Final_06May25_FRENCH.pptx2025-05-07T01:33:01.000Z"8cc78f6452d829c68bd982a601f280cc"CRC64NVMEFULL_OBJECT8655477a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2503_Crystallize Broadcast_Meeting Reel_Final_07May2025.pdf2025-05-20T15:07:53.000Z"73a9bf385fc8ba5c9636410ae30c2726"CRC64NVMEFULL_OBJECT7110955a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2503_Crystallize Broadcast_Meeting Reel_Final_07May2025.pptx2025-05-20T15:05:46.000Z"d046fe031038d88f40bbaa8e7ff3a1c8"CRC64NVMEFULL_OBJECT16487135a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2503_Crystallize Broadcast_Meeting Reel_Final_21May25_FRENCH.pdf2025-05-21T20:15:25.000Z"0771701b732bf7ef6846bcce9728b602"CRC64NVMEFULL_OBJECT4799040a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2503_Crystallize Broadcast_Meeting Reel_Final_21May25_FRENCH.pptx2025-05-21T20:15:11.000Z"020e76690ab2e97aec2cf03e2e59c2ea"CRC64NVMEFULL_OBJECT8656031a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2503_Crystallize Broadcast_Meeting Reel_V2e_06May2025.pdf2025-05-06T18:04:33.000Z"bd7347f8694ae83366b2083508cb768e"CRC64NVMEFULL_OBJECT7195957a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2503_Crystallize Broadcast_Meeting Reel_V2e_06May2025.pptx2025-05-06T18:03:57.000Z"28264188a673770a855f2b24a64bf014"CRC64NVMEFULL_OBJECT16682524a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2503_Crystallize Broadcast_Patient Case_Final_06May25_FRENCH.pdf2025-05-07T01:33:19.000Z"913f3e4df902d88f4b3fe378ecbc81ff"CRC64NVMEFULL_OBJECT475122a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2503_Crystallize Broadcast_Patient Case_Final_06May25_FRENCH.pptx2025-05-07T01:33:01.000Z"d6779db749899236353f596c13313ddd"CRC64NVMEFULL_OBJECT1235416a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2503_Crystallize Satellite Patient Case_v1_06May2025.pdf2025-05-06T18:04:34.000Z"dc5671ee4686cc25f21f58f5c27dc35b"CRC64NVMEFULL_OBJECT528159a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDSJEM2503_Crystallize Satellite Patient Case_v1_06May2025.pptx2025-05-06T18:04:06.000Z"23c0276ac2e451b70478e24e99202c30"CRC64NVMEFULL_OBJECT1269096a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDcrystallize-test.pdf2025-04-03T18:33:33.000Z"a9f584d3e864e2cdce4a8861a686ad61"CRC64NVMEFULL_OBJECT1144114a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDcrystallize-test.pptx2025-04-03T18:33:36.000Z"0210a055b0db44c41207095d3ef367e8"CRC64NVMEFULL_OBJECT3042882a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARDicodec-moa-fr.pdf2025-03-21T23:41:00.000Z"8bb9b356b200ee71c2cdf89d7376cded"CRC64NVMEFULL_OBJECT2456037a34ceb7e8b3a976e90bf448dc2f3c129659b300856441dea648fac8036fa165dSTANDARD